Hutch News
Results per Page:
How does leukemia escape from immunotherapy?
Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements
Vaccination after CAR-T-cell therapy
From the Hill group, Vaccine and Infectious Disease Division and the UW/Fred Hutch Cancer Consortium
What’s new in breast cancer research? San Antonio conference goes hybrid for 2021
Hutch researchers look at overdiagnosis, cardiotoxicity of chemotherapy, cost of a new surveillance method and more
Investment in business development pays dividends for research, patients
Fred Hutch tech transfer specialists help scientists navigate path to bringing innovations to patients
New computational method opens window into immune cell behavior
Approach links T-cell receptor genes to T-cell activity and function at single-cell resolution
Tip Sheet: Disparities in cancer outcomes, catching up on cancer screenings, boosting immunotherapy effectiveness and SARS-CoV-2 origins
Summaries of recent Fred Hutch research findings and other news
5 reasons why a cancer research center has virology expertise
Pathogens can cause diseases, the immune system can fight them
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
What’s new in breast cancer research? SABCS20 goes virtual
Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
Summaries of recent Fred Hutch research findings and other news, plus resources for the American Society of Hematology’s annual meeting
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Fred Hutch completes move-in of Lake Union Steam Plant
106,000-square-foot facility will be home to transformative data science and immunotherapy research aimed at faster cancer breakthroughs
Immunotherapy trial in advanced bladder and other urinary tract cancers shows 'exciting' results
'Practice-changing' data shows patients with advanced urothelial carcinoma survive longer with immune-boosting drug after chemo
Targeting metastatic breast cancer with CAR T-cell immunotherapy
$4M 'Breakthrough' award funds collaborative research aimed at destroying dormant disseminated tumor cells
Nanotech turns pro-tumor immune cells into cancer-killing triple agents
Strategy doubles survival in mice with cancer
Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells
A new Science Translational Medicine paper is first to report how editing a portion of stem cells with CRISPR/Cas9 is sufficient for long-term reactivation of therapeutic hemoglobin
Cancer cells reconnect with their inner child to evade immunotherapy
Turning on an embryonic gene may help some tumors resist immune checkpoint inhibitors
New Research Identifies Gene That Hides Cancer Cells from Immunotherapy
Findings in Developmental Cell show that expression of an early developmental gene prevents the immune system from identifying and attacking cancer cells